NONE

Company

Hepion Pharmaceuticals, Inc.

Filed

March 18, 2019

Accession Number

0001567619-19-007023

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →